Corcept Therapeutics Inc
CORT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001088856
In the last 90 days, Corcept Therapeutics Inc insiders filed 0 open-market purchases and 21 sales; 424 institutions reported holding it in 13F filings for Q2 2026, worth $7.15B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Corcept Therapeutics Inc as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 199
- −11 vs. Q1 2021
- Shares held
- 80.5M
- −1.12M (−1.4%) vs. Q1 2021
- Total value
- $1.77B
- −$171.8M (−8.9%) vs. Q1 2021
- New holders
- 16
- 70 more added
- Sold out
- 27
- 75 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CORT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 424 | $7.15B |
| Q1 2026 | 352 | $3.20B |
| Q4 2025 | 390 | $2.67B |
| Q3 2025 | 429 | $6.41B |
| Q2 2025 | 422 | $5.79B |
| Q1 2025 | 422 | $9.24B |
| Q4 2024 | 368 | $4.25B |
| Q3 2024 | 321 | $4.09B |
| Q2 2024 | 286 | $2.90B |
| Q1 2024 | 285 | $2.36B |
| Q4 2023 | 274 | $2.75B |
| Q3 2023 | 247 | $2.26B |
| Q2 2023 | 225 | $1.81B |
| Q1 2023 | 233 | $1.89B |
| Q4 2022 | 244 | $1.69B |
| Q3 2022 | 239 | $2.23B |
| Q2 2022 | 226 | $2.02B |
| Q1 2022 | 228 | $1.84B |
| Q4 2021 | 208 | $1.59B |
| Q3 2021 | 202 | $1.59B |
| Q2 2021 | 199 | $1.77B |
| Q1 2021 | 210 | $1.94B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Corcept Therapeutics Inc; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Mackay Shields LLC | 0 | $0 | 0.00% | −99,100−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −64,270−100.0% | Sold out |
| Athanor Capital, LP | 0 | $0 | 0.00% | −55,920−100.0% | Sold out |
| Virtue Capital Management, LLC | 0 | $0 | 0.00% | −47,335−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −33,587−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −24,000−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −23,159−100.0% | Sold out |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −22,800−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −15,935−100.0% | Sold out |
| Versor Investments LP | 0 | $0 | 0.00% | −14,700−100.0% | Sold out |
| Fort, L.P. | 0 | $0 | 0.00% | −13,066−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −12,250−100.0% | Sold out |
| Hennion & Walsh Asset Management, Inc. | 0 | $0 | 0.00% | −10,771−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −9,300−100.0% | Sold out |
| LS Investment Advisors, LLC | 0 | $0 | 0.00% | −9,239−100.0% | Sold out |
| Eqis Capital Management, Inc. | 0 | $0 | 0.00% | −9,194−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −8,615−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Hanseatic Management Services Inc | 0 | $0 | 0.00% | −2,001−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −1,779−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −792−100.0% | Sold out |
| Ameritas Investment Company, LLC | 0 | $0 | 0.00% | −609−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −421−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −253−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −124−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −81−100.0% | Sold out |